Home Industries Health Care BizTimes cover story: Mequon company may be on the verge of curing...

BizTimes cover story: Mequon company may be on the verge of curing MS

Multiple sclerosis is a debilitating, often deadly disease that attacks the body’s central nervous system.

It can devastate a victim’s brain, spinal cord, optic nerves and vision. The disease is unpredictable. While treatments and medication currently on the market can help slow down the attacks, there is no cure. Yet. But the cure for MS just might be sitting right in southeastern Wisconsin’s backyard. Endece LLC, a Mequon-based drug discovery company, recently formed Endece Neural, a subsidiary company focused on neurological drug development. More specifically, Endece Neural is pursing the development of a drug that could help repair and even reverse the damage caused by MS. Read more in the cover story of the new edition of BizTimes Milwaukee. 

Multiple sclerosis is a debilitating, often deadly disease that attacks the body's central nervous system.

It can devastate a victim's brain, spinal cord, optic nerves and vision. The disease is unpredictable. While treatments and medication currently on the market can help slow down the attacks, there is no cure. Yet. But the cure for MS just might be sitting right in southeastern Wisconsin's backyard. Endece LLC, a Mequon-based drug discovery company, recently formed Endece Neural, a subsidiary company focused on neurological drug development. More specifically, Endece Neural is pursing the development of a drug that could help repair and even reverse the damage caused by MS. Read more in the cover story of the new edition of BizTimes Milwaukee. 

Stay up-to-date with our free email newsletter

Keep up with the issues, companies and people that matter most to business in the Milwaukee metro area.

By subscribing you agree to our privacy policy.

No, thank you.
Exit mobile version